Engineering a Bispecific Claudin 18.2/TGF-β CAR to Target Claudin 18.2 Tumors and Overcome the Tumor Microenvironment

ASGCT-2024

Jessica Reyes, Ethan BenDavid, Orit Foord, Ximin Chen, Michael Weist, Giulia Parisi, Jiajia Cui, and Melanie L. Munguia poster presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting, May 8, 2024, in Baltimore, Maryland.

View PDF

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

ImmPACT Bio is now part of Lyell Immunopharma

If you have a question about a clinical trial, please contact us at info@immpact-bio.com